Key Record Dates
ClinicalTrials.gov Identifier: | NCT03609424 |
---|---|
Brief Title: | PDR001 Plus Imatinib for Metastatic or Unresectable GIST |
First Submitted : | July 25, 2018 |
First Submitted that Met QC Criteria : | July 25, 2018 |
First Posted : | August 1, 2018 |
Last Update Submitted that Met QC Criteria : | June 22, 2021 |
Last Update Posted : | June 24, 2021 |